IL17A and inflammatory bowel disease: As a proof-of-concept of our investigation, we next analysed the potential clinical benefit of Ab-IPL-IL-17 in the treatment of patients with RA and IBD using ex vivo analysis of patient materials ensuring an equal proportion of male and female donors.